We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee.
- Authors
CAPRIE Steering Committee
- Abstract
Many clinical trials have evaluated the benefit of long-term use of antiplatelet drugs in reducing the risk of clinical thrombotic events. Aspirin and ticlopidine have been shown to be effective, but both have potentially serious adverse effects. Clopidogrel, a new thienopyridine derivative similar to ticlopidine, is an inhibitor of platelet aggregation induced by adenosine diphosphate.
- Publication
Lancet (London, England), 1996, Vol 348, Issue 9038, p1329
- ISSN
0140-6736
- Publication type
Journal Article
- DOI
10.1016/s0140-6736(96)09457-3